Vaxcyte, Inc. (PCVX) Tops Q3 EPS by 27c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($0.83), $0.27 better than the analyst estimate of ($1.10).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• UAE Says Situation Currently Safe After Potential Threat Alert
• SpaceX (SPCX) call put ratio 1 call to 1 put as share price at $153
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'